Product Alert
Latest in Product Alert
Device was recently approved for drug-refractory paroxysmal atrial fibrillation
Jan 08, 2025
Abrysvo and Arexvy labels will caution about risk of rare neurologic disorder
Jan 08, 2025
Health news and commentary gathered by ľֱ staff
Jan 08, 2025
Health news and commentary gathered by ľֱ staff
Jan 02, 2025
Health news and commentary gathered by ľֱ staff
Jan 08, 2025
Health news and commentary gathered by ľֱ staff
Jan 02, 2025
More in Product Alert
Obeticholic acid (Ocaliva) may cause serious liver damage even in PBC patients without cirrhosis
Dec 12, 2024